Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Hikma Pharmaceuticals Plc Shares Outstanding 2016-2024 | HKMPF

Hikma Pharmaceuticals Plc shares outstanding history from 2016 to 2024. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
  • Hikma Pharmaceuticals Plc shares outstanding for the quarter ending December 31, 2024 were 0M, a 0% increase year-over-year.
  • Hikma Pharmaceuticals Plc 2024 shares outstanding were 0.223B, a 0.51% increase from 2023.
  • Hikma Pharmaceuticals Plc 2023 shares outstanding were 0.222B, a 1.13% decline from 2022.
  • Hikma Pharmaceuticals Plc 2022 shares outstanding were 0.225B, a 3.47% decline from 2021.
  
Hikma Pharmaceuticals Plc Annual Shares Outstanding
(Millions of Shares)
2024 223
2023 222
2022 225
2021 233
2020 238
2019 243
2018 242
2017 241
2016 234
2015 201
Hikma Pharmaceuticals Plc Quarterly Shares Outstanding
(Millions of Shares)
2024-12-31
2024-06-30
2023-12-31
2023-06-30
2022-12-31
2021-12-31
2021-06-30
2020-12-31
2020-06-30
2019-12-31
2019-06-30
2018-12-31
2018-06-30
2017-12-31
2017-06-30
2016-12-31
2015-12-31
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $6.153B $3.127B
Hikma Pharmaceuticals PLC develops, manufactures and markets pharmaceutical products. Its brand portfolio includes branded, injectables and generic. Branded segment offers dosage forms and strengths in the anti-infective, cardiovascular, diabetes, central nervous system, oncology and respiratory. Injectables segment offers dosage for CNS, controlled substances, anti-infective, cardiovascular and oncology in form of liquid, semi-liquid and powdered form. Generics segment offers dosage for therapeutic including analgesic, anti-infective, anti-inflammatory, cardiovascular, CNS, respiratory and hormonal. Hikma Pharmaceuticals PLC is based in London, the United Kingdom.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $80.630B 30.25
Zoetis (ZTS) United States $69.973B 26.11
Takeda Pharmaceutical (TAK) Japan $46.997B 9.35
Daiichi Sankyo, - (DSNKY) Japan $42.922B 22.00
BeOne Medicines - (ONC) Cayman Islands $27.080B 0.00
Sandoz Group AG (SDZNY) Switzerland $23.434B 0.00
Merck (MKKGY) Germany $16.421B 12.03
Summit Therapeutics (SMMT) United States $15.269B 0.00
Shionogi (SGIOY) Japan $14.428B 0.00
United Therapeutics (UTHR) United States $13.115B 11.60
Neurocrine Biosciences (NBIX) United States $12.524B 42.90
Orion OYJ (ORINY) Finland $10.594B 28.65
IPSEN (IPSEY) France $9.831B 0.00
Corcept Therapeutics (CORT) United States $7.569B 61.53
Stevanato Group S.p.A (STVN) Italy $7.053B 43.13
Madrigal Pharmaceuticals (MDGL) United States $6.344B 0.00
Grifols, S.A (GRFS) Spain $6.030B 0.00
Ionis Pharmaceuticals (IONS) United States $5.954B 0.00
Ono Pharmaceutical (OPHLF) Japan $5.031B 15.30
Soleno Therapeutics (SLNO) United States $4.031B 0.00
Hypermarcas (HYPMY) Brazil $3.075B 20.23
Crinetics Pharmaceuticals (CRNX) United States $2.824B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.742B 9.61
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.451B 13.25
BioCryst Pharmaceuticals (BCRX) United States $2.113B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $2.016B 0.00
Indivior (INDV) United States $1.932B 8.19
Centessa Pharmaceuticals (CNTA) United Kingdom $1.660B 0.00
Endo (NDOI) United States $1.595B 0.00
ARS Pharmaceuticals (SPRY) United States $1.552B 0.00
Evotec AG (EVO) Germany $1.335B 0.00
Ocular Therapeutix (OCUL) United States $1.295B 0.00
Guardian Pharmacy Services (GRDN) United States $1.272B 0.00
Dyne Therapeutics (DYN) United States $1.173B 0.00
Harrow (HROW) United States $1.125B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.050B 21.00
Enliven Therapeutics (ELVN) United States $1.045B 0.00
Verve Therapeutics (VERV) United States $0.986B 0.00
Akebia Therapeutics (AKBA) United States $0.967B 0.00
Collegium Pharmaceutical (COLL) United States $0.958B 5.17
Avadel Pharmaceuticals (AVDL) Ireland $0.888B 0.00
Ardelyx (ARDX) United States $0.852B 0.00
Elite Pharmaceuticals (ELTP) United States $0.793B 0.00
Cronos Group (CRON) Canada $0.717B 0.00
Xeris Biopharma Holdings (XERS) United States $0.705B 0.00
Xencor (XNCR) United States $0.608B 0.00
KalVista Pharmaceuticals (KALV) United States $0.604B 0.00
Altimmune (ALT) United States $0.570B 0.00
USANA Health Sciences (USNA) United States $0.569B 12.37
Relay Therapeutics (RLAY) United States $0.547B 0.00
Regulus Therapeutics (RGLS) United States $0.546B 0.00
Bioventus (BVS) United States $0.538B 13.65
Theravance Biopharma (TBPH) United States $0.532B 0.00
AleAnna (ANNA) United States $0.504B 0.00
Zevra Therapeutics (ZVRA) United States $0.494B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.450B 0.00
Oruka Therapeutics (ORKA) United States $0.437B 0.00
Siga Technologies (SIGA) United States $0.437B 9.13
Tourmaline Bio (TRML) United States $0.427B 0.00
Organogenesis (ORGO) United States $0.410B 0.00
Liminatus Pharma (LIMN) United States $0.375B 0.00
Savara (SVRA) United States $0.356B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.338B 9.14
Aquestive Therapeutics (AQST) United States $0.323B 0.00
Heron Therapeutics (HRTX) United States $0.305B 0.00
Nature's Sunshine Products (NATR) United States $0.271B 24.86
Tonix Pharmaceuticals Holding (TNXP) United States $0.238B 0.00
Esperion Therapeutics (ESPR) United States $0.212B 0.00
Nanobiotix S.A (NBTX) France $0.211B 0.00
MediWound (MDWD) Israel $0.206B 0.00
OmniAb (OABI) United States $0.194B 0.00
ProKidney (PROK) United States $0.193B 0.00
4D Molecular Therapeutics (FDMT) United States $0.191B 0.00
Profound Medical (PROF) Canada $0.191B 0.00
Aldeyra Therapeutics (ALDX) United States $0.183B 0.00
Larimar Therapeutics (LRMR) United States $0.166B 0.00
Aclaris Therapeutics (ACRS) United States $0.157B 0.00
Galectin Therapeutics (GALT) United States $0.153B 0.00
Journey Medical (DERM) United States $0.152B 0.00
Innate Pharma SA (IPHYF) France $0.145B 0.00
Avita Medical (RCEL) United States $0.137B 0.00
VAXART, INC (VXRT) United States $0.132B 0.00
Lexeo Therapeutics (LXEO) United States $0.130B 0.00
Lyell Immunopharma (LYEL) United States $0.129B 0.00
Inhibikase Therapeutics (IKT) United States $0.123B 0.00
Protara Therapeutics (TARA) United States $0.118B 0.00
Achieve Life Sciences (ACHV) Canada $0.116B 0.00
Korro Bio (KRRO) United States $0.116B 0.00
Champions Oncology (CSBR) United States $0.115B 18.84
Ironwood Pharmaceuticals (IRWD) United States $0.114B 0.00
Nektar Therapeutics (NKTR) United States $0.106B 0.00
Fractyl Health (GUTS) United States $0.105B 0.00
Cardiol Therapeutics (CRDL) Canada $0.102B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.101B 0.00
Cassava Sciences (SAVA) United States $0.096B 0.00
Wellgistics Health (WGRX) United States $0.087B 0.00
Nutriband (NTRB) United States $0.087B 0.00
Surrozen (SRZN) United States $0.086B 0.00
Dominari Holdings (DOMH) United States $0.083B 0.00
Arch Biopartners (ACHFF) Canada $0.083B 0.00
Unicycive Therapeutics (UNCY) United States $0.080B 0.00
ESSA Pharma (EPIX) Canada $0.077B 0.00
Vivani Medical (VANI) United States $0.075B 0.00
Pyxis Oncology (PYXS) United States $0.072B 0.00
Inotiv (NOTV) United States $0.070B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.065B 48.33
Assertio Holdings (ASRT) United States $0.060B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
PMV Pharmaceuticals (PMVP) United States $0.057B 0.00
NRx Pharmaceuticals (NRXP) United States $0.056B 0.00
Rafael Holdings (RFL) United States $0.055B 0.00
Metagenomi (MGX) United States $0.054B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.054B 0.00
Gain Therapeutics (GANX) United States $0.053B 0.00
Telomir Pharmaceuticals (TELO) United States $0.052B 0.00
Context Therapeutics (CNTX) United States $0.051B 0.00
Avalo Therapeutics (AVTX) United States $0.050B 0.00
Century Therapeutics (IPSC) United States $0.050B 0.00
Klotho Neurosciences (KLTO) United States $0.050B 0.00
Prelude Therapeutics (PRLD) United States $0.049B 0.00
Mural Oncology (MURA) Ireland $0.042B 0.00
Iterum Therapeutics (ITRM) Ireland $0.040B 0.00
ElectroCore (ECOR) United States $0.038B 0.00
Karyopharm Therapeutics (KPTI) United States $0.038B 0.00
Acrivon Therapeutics (ACRV) United States $0.037B 0.00
Jupiter Neurosciences (JUNS) United States $0.037B 0.00
PolyPid (PYPD) Israel $0.033B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.033B 0.00
China SXT Pharmaceuticals (SXTC) China $0.029B 0.00
SCYNEXIS (SCYX) United States $0.029B 0.00
Enlivex Therapeutics (ENLV) Israel $0.026B 0.00
Tempest Therapeutics (TPST) United States $0.025B 0.00
FibroGen (FGEN) United States $0.023B 0.00
Relmada Therapeutics (RLMD) United States $0.023B 0.00
DURECT (DRRX) United States $0.021B 0.00
Natural Alternatives (NAII) United States $0.020B 0.00
BioVie (BIVI) United States $0.019B 0.00
Mannatech (MTEX) United States $0.019B 0.00
Carisma Therapeutics (CARM) United States $0.018B 0.00
BioLineRx (BLRX) Israel $0.018B 0.00
Ernexa Therapeutics (ERNA) United States $0.018B 0.00
Lipocine (LPCN) United States $0.018B 0.00
Vivos Therapeutics (VVOS) United States $0.016B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.016B 0.00
CASI Pharmaceuticals (CASI) China $0.016B 0.00
ProPhase Labs (PRPH) United States $0.014B 0.00
Lyra Therapeutics (LYRA) United States $0.014B 0.00
VYNE Therapeutics (VYNE) United States $0.014B 0.00
TherapeuticsMD (TXMD) United States $0.013B 0.00
Cosmos Health (COSM) United States $0.012B 0.00
Minerva Neurosciences (NERV) United States $0.012B 2.16
Scienture Holdings (SCNX) United States $0.012B 0.00
Citius Pharmaceuticals (CTXR) United States $0.011B 0.00
Phio Pharmaceuticals (PHIO) United States $0.011B 0.00
Mangoceuticals (MGRX) United States $0.011B 0.00
Ainos (AIMD) United States $0.010B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.010B 0.00
GlycoMimetics (CBIO) United States $0.010B 0.00
Talphera (TLPH) United States $0.009B 0.00
Traws Pharma (TRAW) United States $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.009B 0.00
Biomerica (BMRA) United States $0.008B 0.00
Nuvilex (PMCB) United States $0.007B 0.00
Alaunos Therapeutics (TCRT) United States $0.007B 0.00
SHINECO (SISI) China $0.007B 0.00
Incannex Healthcare (IXHL) Australia $0.006B 0.00
TransCode Therapeutics (RNAZ) United States $0.006B 0.00
Aptorum Group (APM) United Kingdom $0.005B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.005B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.005B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
Redhill Biopharma (RDHL) Israel $0.004B 0.00
Indaptus Therapeutics (INDP) United States $0.004B 0.00
Xenetic Biosciences (XBIO) United States $0.004B 0.00
CERo Therapeutics Holdings (CERO) United States $0.004B 0.00
Heatwurx (PCSA) United States $0.004B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
SciSparc (SPRC) Israel $0.003B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
Plus Therapeutics (PSTV) United States $0.003B 0.00
PainReform (PRFX) Israel $0.003B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
InMed Pharmaceuticals (INM) Canada $0.003B 0.00
Jaguar Animal Health (JAGX) United States $0.003B 0.00
Aditxt (ADTX) United States $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
Conduit Pharmaceuticals (CDT) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
MEI Pharma (MEIP) United States $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00